Patient Immunotherapy Summit: Ovarian Cancer Brief January 8, 2024January 8, 2024 Max Mallet It is important for the public to be aware of the scope of ovarian cancer, as over 80% of patients will experience a recurrence of the disease. Kunle Odunsi, MD, PhD, the Director of the University of Chicago Medicine Comprehensive Cancer Center and CRI Scientific Advisory Council associate director, is an expert on ovarian cancer and a titan in the field of cancer immunotherapy research. Read more: Post navigation Patient Immunotherapy Summit: Pancreatic Cancer Brief Read Story Patient Immunotherapy Summit: I’m the Answer to Cancer™ Jeff’s Patient Story Read Story
